The aristaless-related homeobox (ARX) transcription factor is involved in the development of GABAergic and cholinergic neurons in the forebrain. ARX mutations have been associated with a wide spectrum of neurodevelopmental disorders in humans, among which the most frequent, a 24 bp duplication in the polyalanine tract 2 (c.428_451dup24), gives rise to intellectual disability, fine motor defects with or without epilepsy. To understand the functional consequences of this mutation, we generated a partially humanized mouse model carrying the c.428_451dup24 duplication (Arx and an up-regulation of genes normally not expressed in this cell type, suggesting abnormal interneuron development. Accordingly, interneuron migration was altered in the cortex and striatum between E15.5 and P0 with consequences in adults, illustrated by the defect in the inhibitory/excitatory balance in Arx dup24/0 basolateral amygdala. Altogether, we showed that the c.428_451dup24 mutation disrupts Arx function with a direct consequence on interneuron development, leading to hyperactivity and defects in precise motor movement control and associative memory. Interestingly, we highlighted striking similarities between the mouse phenotype and a cohort of 33 male patients with ARX c.428_451dup24, suggesting that this new mutant mouse line is a good model for understanding the pathophysiology and evaluation of treatment.
Introduction
So far, more than 100 mutations have been identified in human in the aristaless-related homeobox (ARX) transcription factor encoding gene, located on the X chromosome. Depending on the phenotypic severity, ARX mutations can be divided into two groups: (i) a group with brain malformations, including X-linked lissencephaly with abnormal genitalia (1) (2) (3) , hydranencephaly with abnormal genitalia and Proud syndrome (4) , and (ii) a group without brain malformation, comprising X-linked intellectual disability (ID) with or without epilepsy and Partington syndrome (ID and dystonic movements of the hands) (see for reviews [5] [6] [7] .
ARX is involved in GABAergic neuron development in the cortex, hippocampus and basal ganglia, and in cholinergic neuron development in the striatum, medial septum and ventral forebrain nuclei (2, 5, 8, 9) . Accordingly, its expression is controlled by Dlx transcription factors (10, 11) , which are important for the differentiation of telencephalic GABAergic neurons (12) and it regulates the expression of several genes important for brain development, in particular interneuron development (13) (14) (15) (16) .
ARX protein contains a homeodomain implicated in DNA binding, an aristaless domain at the C-terminus, responsible for transcriptional activation, an octapeptide domain close to the N-terminus, involved in transcriptional repression, and four polyalanine tracts whose function is not well known (17) . Interestingly, the majority of ARX mutations affects the two first polyalanine tracts of ARX protein. In particular, the in-frame 24 bp duplication (c.428_451dup24), that expands the normal 12 polyalanine tract 2 to 20 (aa 144-155), occurs in 67-76% of unrelated ARX mutated patients without brain malformation (7, 18) . Originally, the c.428_451dup24 mutation was reported to cause variable phenotypes, including West syndrome, Partington syndrome and non-syndromic X-linked ID. However, recent clinical re-evaluation of c.428_451dup24 patients suggested that this mutation constitutes a recognizable clinical syndrome with ID, an oro-lingual apraxia and a very specific upper limb distal motor apraxia associated with a pathognomonic handgrip and variable epilepsy expression (19) .
So far, the effect of ARX polyalanine expansions is not well understood. Overexpression experiments have suggested that they may cause protein aggregation and subsequent increased cell death in transfected cells (5, 20, 21) although two studies in transgenic mice for two different expansions in ARX polyalanine tracts [c.304ins(GCG) 7 and c.428_451dup24] have reported the absence of detectable protein aggregates or cell death in vivo (22, 23) . More recently, ARX polyalanine expansions have been shown to spontaneously promote the inappropriate selfassembly of these sequences into a-helical clusters with diverse oligomeric states, likely leading to the disruption of normal protein interactions (24) . It has also been suggested that polyalanine expansions may affect directly ARX transcription activity. ARX can act both as a transcriptional repressor and activator (17, 25) . In vitro studies suggested that polyalanine expansions result in an increased repression activity (17) . In contrast, studies in transfected cells showed less or decreased repression of some ARX known target genes with c.304ins(GCG) 7 and c.428_451dup24, suggesting a partial loss-of-function effect (6, 26, 27) . Nevertheless, it is more likely that these polyalanine expansions result in the misregulation of a subset of target genes, as shown for c.304ins(GCG) 7 mutation in mice (26) .
To better understand the in vivo effect of polyalanine expansions on ARX functions, two mouse models for the c.304ins(GCG) 7 mutation have been generated (22, 23) and their phenotypes were very similar to human patients. So far, only one model has been generated for the c.428_451dup24 (called dup24) mutation and was reported to have no major phenotype (23) , although some of ARX target genes were found misregulated in these mice (27) . Unlike the previous dup24 mouse model which was created by the insertion of 24 bp expansion in the polyalanine tract 2 of the mouse Arx gene (23), we here generated and characterized a new partially humanized knock-in mouse line carrying part of human ARX exon 2 coding for the polyalanine tract 1 and the expanded polyalanine tract 2.
Results
Decreased Arx mRNA and protein expression in Arx dup24/0 mutant brains
The Arx dup24/0 mutant mouse line was generated as described in Figure 1A and B and the Supplementary Material. Interestingly, we found that the polyalanine tract 2 containing the duplication of 24 bp is rather unstable at the DNA level and can result in mosaicism in a small fraction of cells (see Supplementary Material, Fig. S1 ).
Brains from Arx dup24/0 males looked normal in size and did not show any gross malformation at E15. 1C) and a 23% reduction of ARX protein in Arx dup24/0 mice ( Fig. 1D and E), which is consistent with 8-50%
decreased protein amount reported in another mouse model for the same mutation (27) . We also quantified Arx expression in adult brain, and found a similar decrease at the mRNA level which however did not reach statistical significance (ratio Arx GAC GGC GCA GGG GCC GCC GCG GCA GCC GCG GCC GCG GCC GCC GCG GCA GCC GCG GCC GCG GCC GCC GCG GCC TGG  CTG CCG CGT CCC CGG CGG CGC CGT CGG CGC CGG CGC CGG CGG CGC CGT CGG CGC CGG CGC CGG : 0.88 6 0.15, n ¼ 4, P ¼ 0.47, unpaired t-test). Unfortunately, the level of ARX protein was too low in adult to allow a precise quantification by western blot.
Eight percent of Arx dup24/0 pups presented with infantile spams, but no increased susceptibility to induced epilepsy in adult
As infantile spasms were occasionally described in ARX c.428_451dup24 patients (28), we tested Arx dup24/0 males for the presence of infantile spontaneous motor spasms at P7, P9 and P11 during 30 min by video-monitoring. None of the 34 Arx wt/0 pups displayed any spontaneous motor spasms, whereas two of the 25 Arx dup24/0 pups (corresponding to 8% of Arx dup24/0 pups) showed spasms ( Fig. 2A and B) . In addition, we tested the susceptibility of adult Arx dup24/0 males to seizures induced by injection of a pro-convulsive agent, the pentylenetetrazole (PTZ Fig. S3 ). In the Down-regulation of interneuron specific genes in Arx dup24/0 forebrain at E15.5
To gain better insights into the molecular consequences associated with the 24 bp duplication, we performed genome-wide RNA sequencing (RNA-seq) on embryonic E15.5 forebrains from Arx dup24/0 and Arx wt/0 males and found 255 and 171 genes significantly up-and down-regulated in Arx dup24/0 mice, respectively (DEseq2 algorithm, exon reads, P < 0.025 and Supplementary Material, Table S2 ). Pathway analysis unraveled major differences between up-and down-regulated genes ( Fig. 5A ): while down-regulated genes were endowed with synaptic transmission-related functions, up-regulated genes were mostly related to various aspects of central nervous system development and DNA interaction (Fig. 5A ). Of note, some of the previously identified Arx target genes (Lmo1, Lmo3, Lmo4, Shox2, Gbx2, Lhx7/8, Ebf3, Rasgef1b; (13-15)) were not found significantly deregulated in Arx dup24/0 E15.5 forebrains.
To relate our results to GABAergic interneuron (IN) development for which Arx is known to be important, we took advantage of three previous experimental datasets ( [31] [32] [33] , which investigated genes specifically expressed (markers) or silenced in GABAergic INs. We found down-regulated genes highly enriched in interneuron markers, namely cortical (E13 P < 1.4e-21, E14 P < 7.8e-19, hypergeometric test, Bonferroni correction) and ganglionic eminence (GE) IN precursors (E14 P < 4.6e-36, hypergeometric test, Bonferroni correction) or mature IN (P30 P < 4.2e-9, hypergeometric test, Bonferroni correction) (Fig. 5B) . In contrast, up-regulated genes were enriched in genes normally silenced in IN (E13 P < 8e-87, E14 P < 2.1e-76, hypergeometric test, Bonferroni correction; Fig. 5B ) with enrichment scores consistent amongst the three datasets. Moreover, we found a strong correlation between the specificity of IN markers and the degree of enrichment in Arx dup24/0 downregulated genes and reciprocally between the specificity of IN silenced genes and the degree of enrichment in Arx dup24/0 upregulated genes (Fig. 5C ). This suggests that the 24 bp duplication causes a specific down-regulation of highly specific IN markers and an up-regulation of genes not meant to be expressed in INs in normal conditions. To ensure the reliability of our RNA-seq results, a subset of dysregulated genes were selected and analyzed in E15.5 forebrains of Arx dup24/0 and Arx wt/0 control littermates using real-time quantitative polymerase chain reaction (RT-qPCR). For all genes analyzed, RT-qPCR results confirmed the deregulation observed in RNA-seq experiments, although not always with the same magnitude or level of statistical significance (Fig. 5D ). to the cortex and to a lesser extent, to the hippocampus and (ii) from the GE to the subpallial structures including the striatum.
Delayed interneuron development in
We then investigated glutamatergic neuronal populations at E15.5 using different projecting neuron markers including markers of radial glia cells (Pax6), intermediate progenitors (Tbr2) and post-mitotic neurons (Tbr1) in the cortex. We did not observe any difference in the number of Pax6þ and Tbr2þ cells, but we observed a small decrease (7.2%) into the CP following the tangential migration. In adult, these defects in cortical IN distribution were still present, but more subtle with ARX and CB markers and absent with CR, PV and SST markers (Fig. 6I ). In the striatum of P0 mice, although there was no statistical difference between the number of ARXþ, CBþ or CRþ cells, we observed a 22.8% decreased number of ChATþ cells ( Inhibitory/excitatory imbalance at hippocampal to basolateral amygdala projections in adult Arx dup24/0 males Part of the developmental modifications observed in IN populations could explain the contextual fear conditioning alteration observed in adult Arx dup24/0 animals. We previously demonstrated that hippocampal inputs to basolateral amygdala (BLA) neurons controlled the intensity of the conditioned fear response (36) . To challenge this hypothesis, we tested the synaptic response of hippocampal projections to the BLA using optogenetic stimulation methods combined with electrophysiological detection of GABAergic synaptic currents in BLA neurons. Our aim was to examine if the c.428_451dup24 mutation could redefine the inhibitory/excitatory (I/E) balance in this feed-forward neuronal circuit. To achieve this, we performed viral infection of the Channelrhodopsin-2 (ChR2) in caudal hippocampal neurons to allow expression of ChR2 in some BLA projecting neurons ( Fig. 7A and B) . We recorded light-evoked synaptic currents in BLA neurons at two membrane potentials allowing separating direct excitatory inputs from ChR2 expressing cells (at À70 mV) and indirect inhibitory inputs from recruited local INs which activation will give rise to GABAergic currents (at 0 mV) (Fig. 7B) . The resulting I/E balance theoretically dictates the capacity of incoming long range inputs in activating downstream neurons. Light-evoked excitatory potentials (EPSCs) were first compared by recording neurons at À70 mV, but their amplitude was not different between Arx dup24/0 and Arx wt/0 mice (Fig. 7D) . We then recorded light-evoked inhibitory potentials at 0 mV, and observed a strong tendency toward a decrease in their amplitude in Arx dup24/0 animals (Fig. 7D) . However, the I/E balance at hippocampo-BLA afferents was significantly decreased by the 24 bp duplication (Fig. 7C) Neurological and motor examination of ARX patients did not show any spasticity, nor motor deficit. Fine motor skills were impaired in all patients with a range of severity; strikingly, patient's hand grasping was very specific. ARX patients scored higher on the balance subtest of the Lincoln-Oseretsky motor development scale (LOMDS) than IQ-and age-matched Down syndrome (DS) patients (t ¼ 3.5, P ¼ 0.003, Student t-test). Moreover, a writing speed test showed that they were significantly more impaired than DS patients (age-and IQ-matched) with 25 letters copied on average for ARX patients and 40 letters copied for DS patients (t ¼ 2.1, P < 0.05, Student t-test).
Epilepsy manifestations were observed in 11 of the 33 ARX c.428_451dup24 patients. Three out of the 33 ARX c.428_451dup24 patients (9.1%) presented with West syndrome [i.e. infantile spasms, psychomotor regression and hypsarythmia on the electroencephalography (EEG)] with a mean age onset of 5 months, [4] [5] [6] [7] . The other eight patients showed various types of seizures including absence, complex partial seizures and generalized tonic-clonic seizures with a mean age onset of 10.1 years, [1.8-33] . Only three patients required multiple antiepileptic treatment. It was possible after a few years to stop the antiepileptic treatment in five patients.
Discussion
We describe here the characterization of a new mouse model partially humanized for the ARX c.428_451dup24 duplication, leading to polyalanine expansion in ARX tract 2. Our mouse model supports previous findings showing that this mutation causes a decreased expression of Arx (23, 27, 38) . It has been shown that polyalanine expansions cause inappropriate oligomerization of the protein, which is targeted for clearance by the cellular quality-control machinery (24, 39) , thus possibly explaining the decreased amount of ARX protein that we observed both in western blot (Fig. 1E) and by immunohistochemistry (Supplementary Material, Fig. S2 ). However, this does not explain $12% decreased amount of mRNA that we observed both at E15.5 and adult stage. Interestingly, we found that the 24 bp duplication leads to DNA instability of the polyalanine tract 2 (see Supplementary Material, Fig. S1 ), with the recurrent apparition of products of smaller and larger size but always in frame, suggesting that they are not the result of a technical bias due to PCR amplification. Unfortunately, we were not able to detect the corresponding proteins by western blot, either due to a lack of sensitivity of the antibody (as the amount of these products is very low compared to the 24 bp duplication mutated protein) or because these mRNAs may be unstable and thus degraded. This last hypothesis would give a possible explanation for the decreased amount of Arx mRNA observed. Alternatively, it could also be a direct consequence of the presence of 24 bp duplication that would make the mRNA less stable. Interestingly, this instability was also found in ARX c.428_451dup24 patient DNA extracted from blood cells, suggesting that the same situation also occurs in human.
The behavioral defects observed in the partially humanized Arx dup24/0 mouse model are strikingly similar to the symptoms observed in ARX c.428_451dup24 patients (Table 1) , as far as human/mouse neurobehavioral phenotypes can be compared. ARX patients have initially been described with a strong phenotypic heterogeneity. However, a recent clinical re-evaluation of 27 patients from 12 different families, confirmed by the present description of 6 additional patients, all evaluated by the same clinician, revealed that this mutation constitutes a recognizable clinical syndrome with ID, an oro-lingual apraxia and a very specific upper limb distal motor apraxia with a very specific hand grasping but a normal gross motor function (19; this study). We observed good correspondence between Arx dup24/0 mice and ARX patients concerning hyperactivity and stereotypy manifestations. Strikingly, the percentage of Arx dup24/0 P7-P11 pups presenting infantile spasms (8%) was very similar to the 9.1% of ARX patients presenting with West syndrome (Table 1) . However, we remarked differences concerning the manifestation of anxiety (most ARX patients had some level of anxiety whose only a minority had severe anxiety, whereas Arx dup24/0 mice had similar level of anxiety than Arx wt/0 mice, although the presence of hyperactivity and stereotypy in new environments may reveal some level of anxiety). No change was noted in working or spatial memory, but we observed alteration in contextual memory for fear in mice. The hyperactivity and the alteration in associative memory in Arx dup24/0 mice are very similar to the phenotypes described for Dlx1 À/À mutant mice (40, 41) , and thus consistent with a defect in interneuron development. Similarly to ARX patients, Arx dup24/0 mutant mice have good performance in the gross motor coordination as revealed in the rotarod test, whereas they presented with fine motor defects in the MoRaG test, automated gait analysis and the beam walking test, more suggestive of an alteration of gait and proprioceptive and fine motor abilities. It is interesting to note that motor defects were more easily detected in mutant mice than defects in learning and memory abilities. This is possibly due to the better sensitivity of mouse tests assessing locomotor functions than neuropsychological tests which would allow only the detection of severe phenotypes in mice. Moreover, ARX c.428_451dup24 patients are considered to have mild ID, thus, although we detected an associative memory phenotype in mice, the cognitive phenotypes could be too mild to be significantly detected using the current battery of tests. Previously, two mouse models for the expansion in the polyalanine tract 1 [c.304ins(GCG) 7 ] have been described (22, 23) . These mouse models displayed infantile motor spasms, severe seizures, distinctive EEG abnormalities and cognitive and behavioral abnormalities, such as impaired associative learning, abnormal social interaction and contradictory results concerning anxiety (22, 23) . Interestingly, our mouse model presents similarities with these Arx c.304ins(GCG) 7 mouse models, in particular concerning the infantile spams and the alteration in associative learning. However, it shows several differences, suggestive of a milder phenotype, with a smaller proportion of animals presenting infantile spontaneous motor spasms [5 affected over 15 pups for the Arx c.304ins(GCG) 7 mouse model and only 2 affected over 25 pups for our Arx c.428_451dup24 mouse model], the absence of increased susceptibility to induced epilepsy for Arx c.428_451dup24 mouse model and the fear conditioning test for which Arx c.304ins(GCG) 7 mice present alteration in both the cue and the contextual memories (22, 23) whereas Arx c.428_451dup24 mouse model is only affected for contextual memory. Those results are in agreement with what has been reported for human patients presenting ARX c.428_451dup24 mutations who are described as less severely affected than patients with ARX c.304ins(GCG)7 expansion (28, 42, 43) . Another mouse model for ARX c.428_451dup24 mutation has been recently described with much more pronounced spontaneous seizures activity than our model (38) . This difference may be due to a different environmental condition affecting the animals. This model was generated by Kitamura et al. (23) on 129SV ES cells and then bred on C57BL/6J (B6J) and backcrossed on C57BL/6NHsd (B6NHsd) genetic background in Jackson's publication (38) . The only difference with our model is that the latter was backcrossed on B6NTac genetic background. Thus, we may propose that the B6NHsd are more prone to seizures than the B6NTac. Indeed, differences in epilepsy and death susceptibility after pro-convulsant injection have been reported between different B6N strains (44) . However, it is interesting to note that originally, when Kitamura et al. (23) first published this mouse model, they did not observe any particular phenotype including epilepsy. In addition, the phenotype we observed in our mouse model is much closer to the rather mild phenotype observed in the patients, especially concerning the frequency and severity of infantile spasms and epilepsy. The most striking features of our mouse model is that it also recapitulates the fine motor defects which is a common hallmark of ARX c.428_451dup24 patients (19) .
Comparison of our RNA-seq results performed on E15.5 Arx dup24/0 and Arx wt/0 forebrains with published databases revealed a global decreased expression of genes important for interneuron development and/or migration (Fig. 3) . Accordingly, we found defects in interneuron subpopulations, especially in the number and distribution of CBþ, CRþ and ChATþ cells at E15.5. At P0, we showed an accumulation of IN in the periphery of the CP and a decreased proportion in the center of the CP. This observation may be caused by IN being delayed to penetrate cortical layers by radial migration (as previously suggested for Arx knockout mice; (2)). A defect in neuronal migration is further strengthened by the enrichment of genes involved in cell migration among deregulated genes in E15. (49, 50) . This defect may also concern the lateral ganglionic eminence (LGE) (responsible for the production of majority of striatal neurons) and caudal ganglionic eminence (CGE) (responsible for the production of neurons of cortex, amygdala and hippocampus) but it is difficult to tell just from RNA-seq results, as these three structures lack specific gene signature (51, 52) . Thereby, an alteration of the generation/maturation of the MGE, LGE and CGE neurons would explain the decreased number of different neuron types, namely CBþ, CRþ and ChATþ cells observed in the cortex and subpallial structures at E15.5, and the decreased expression of genes important for striatal neuron development such as Foxp1, Drd1 and Tac1 (Fig. 3D) . Further analysis using different protein markers or in situ hybridization probes will be necessary to fully characterize this maturation delay. Finally, as impaired interneuron function was also suggested by epilepsy manifestations both in Arx dup24/0 pups and ARX c.428_451dup24 patients, we thus investigated the consequences of a defect in interneuron migration and/or development at adult stage by analyzing electrophysiological properties at hippocampal to BLA connections. We detected an alteration of I/E balance, which is interesting to correlate with the alteration observed in the contextual fear conditioning as efficient hippocampal projections to the BLA have been shown to be crucial for the aversive conditioned response in mice (36) .
Arx was shown to be also important for excitatory neuron development (34, 35, 53, 54) , thus we also looked at markers of pyramidal neurons. The slight decreased in the number of Tbr1þ cells observed at E15.5 suggests that the global delay of neuronal generation/maturation suspected in GE may also be present in this neuronal population. However, we did not detect any change in the expression or localization of Pax6 or Tbr2þ cells in the cortex. Further studies would be required to fully investigate this aspect. However, the absence of increased susceptibility to induced epilepsy in Arx dup24/0 adult males is not in favor of major defects in pyramidal neurons.
In conclusion, our new mouse model expressing the human ARX c.428_451dup24 mutation appears as a relevant model to further dissect the pathophysiological effects of this mutation and for the development of therapeutic approaches, as it shows striking similarities with human patients, especially in behavior with hyperactivity and defects in fine motor and proprioceptive abilities. It highlights alteration of generation, migration and functioning of interneurons in various regions of the brain as a direct consequence of 24 bp duplication effect on Arx function. Even if most of adult interneurons recover their position, the rescue is not complete, inducing a series of changes in the overall activity, a defect in associative learning and in controlling fine motor movements.
Materials and Methods

Mouse line and ethical statement
The Arx KI.ICS mutant mouse line (noted Arx dup24/0
) was generated and analyzed in the mouse genetic background C57BL/6N*129Sv/ Pas*C57BL/6J (95.3*3.1*1.5%, Supplementary Material, Fig. 1A and B). All mouse experimental procedures were performed in agreement with the EC directive 2010/63/UE86/609/CEE for the care and use of laboratory animals and every effort was made to minimize the number of animals used and their suffering. The behavioral pipeline was approved by the local animal care, use and ethic committee of the Institute of Genetics and of Molecular and Cellular Biology (IGBMC) under accreditation number 2012-139. The experimental design and procedures of electrophysiological experiments were performed in accordance with the animal care guidelines issued by the animal experimental committee of Bordeaux Universities (CE50, A5012009).
Behavioral experiments
Five cohorts of Arx wt/0 and Arx dup24/0 male mice were used for behavioral experiments (8-15 per genotype and per cohort) and 9-31 weeks old mice were tested for circadian activity, general health, basic neurological reflexes, anxiety related behavior, susceptibility to despair, learning and memory (emotional, spatial), working memory, social recognition, proprioceptive abilities, specific motor abilities, gait analysis and susceptibility to epileptic seizures. One cohort of P7-P11 pups (25 mutants and 34 controls males) were investigated for spontaneous infantile spasms. The behavioral tests and cohorts used are described in the Supplementary Material.
Electrophysiology
All electrophysiological experiments were performed on 2 months old males (five Arx dup24/0 and three Arx wt/0 littermates).
Mice were injected in the caudal hippocampus with adenoassociated viruses (AAV) containing the channel rhodopsin gene ChR2. After waiting 4 weeks for ChR2 gene expression, we prepared coronal BLA-containing acute slices from infected mice and recorded neurons visualized with infrared video microscopy in the voltage clamp mode at À70 mV [to record AMPAR-mediated excitatory postsynaptic currents (EPSCs)] or 0 mV (to record GABA A R-mediated inhibitory postsynaptic currents) (36) . Hippocampo-BLA monosynaptic EPSCs and disynaptic inhibitory postsynaptic currents were elicited by 1 ms light-stimulations. Details of the electrophysiological procedures used are described in the Supplementary Material.
RNA-seq libraries and analysis
Total RNA was Trizol-extracted from three wild-type and three mutant frozen embryonic forebrains (including developing cortex and basal ganglia). 
Immunohistochemistry on brain sections and cell counting
Brains from 13-week-old, post-natal day 0 (P0) and day-postcoïtum 15.5 (E15.5) Arx dup24/0 and Arx wt/0 males (4-6 of each genotype) were harvested as described elsewhere (55) . Antibodies and immunohistochemistry procedures are described in the Supplementary Material.
ARX c.428_451dup24 patients
After explaining the aims of the study, all patients and their guardians gave written informed consent for the study, which was approved by the Ethical Committee of French Public Hospitals (Comité de Protection des Personnes Lyon-Sud Est II, 2010-A00327-32, 09/22/2010).
Supplementary Material
Supplementary Material is available at HMG online.
